## Abstract ## Objective To investigate the correlation between the degree of dermal fibrosis and myofibroblast infiltration using clinical assessments of skin thickness and hardness in systemic sclerosis (SSc). ## Methods Eleven patients with diffuse SSc and 10 healthy controls were evaluated u
MicroRNA-29, a key regulator of collagen expression in systemic sclerosis
✍ Scribed by Britta Maurer; Joanna Stanczyk; Astrid Jüngel; Alfiya Akhmetshina; Michelle Trenkmann; Matthias Brock; Otylia Kowal-Bielecka; Renate E. Gay; Beat A. Michel; Jörg H. W. Distler; Steffen Gay; Oliver Distler
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 394 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Although a multisystem disease, systemic sclerosis (SSc) most commonly affects the skin. The skin lesion is characterized by progressive changes, chief amongst which are vascular abnormalities, including endothelial cell (EC) injury and death, and dermal fibrosis. The pathogenesis of the vascular ch
## Abstract ## Objective To examine the expression and regulation of interleukin‐21 (IL‐21) and IL‐21 receptor (IL‐21R) in patients with systemic sclerosis (SSc; scleroderma). ## Methods Skin biopsy specimens were obtained from 23 patients with SSc and 15 healthy controls. IL‐21/IL‐21R messenger
## Abstract ## Objective Both genetic and epigenetic factors play an important role in the pathogenesis of lupus. The aim of this study was to examine methyl‐CpG–binding protein 2 gene (__MECP2__) polymorphisms in a large cohort of patients with lupus and control subjects, and to determine the fun
## Abstract ## Objective To clarify the clinical significance of serum levels of pulmonary and activation‐regulated chemokine (PARC) in the diagnosis and monitoring of pulmonary fibrosis (PF) in patients with systemic sclerosis (SSc) and to compare PARC levels with KL‐6 antigen or surfactant prote